Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZBH | Common Stock | Options Exercise | $0 | +1.12K | +8.5% | $0.00 | 14.3K | Dec 3, 2022 | Direct | F1 |
transaction | ZBH | Common Stock | Tax liability | -$55.6K | -453 | -3.16% | $122.76 | 13.9K | Dec 3, 2022 | Direct | F2 |
transaction | ZBH | Common Stock | Options Exercise | $0 | +954 | +6.87% | $0.00 | 14.8K | Dec 3, 2022 | Direct | |
transaction | ZBH | Common Stock | Tax liability | -$56.7K | -462 | -3.11% | $122.76 | 14.4K | Dec 3, 2022 | Direct | F2 |
transaction | ZBH | Common Stock | Options Exercise | $0 | +1.57K | +10.93% | $0.00 | 15.9K | Dec 3, 2022 | Direct | |
transaction | ZBH | Common Stock | Tax liability | -$107K | -869 | -5.45% | $122.76 | 15.1K | Dec 3, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZBH | Restricted Stock Units | Options Exercise | $0 | -1.12K | -100% | $0.00* | 0 | Dec 3, 2022 | Common Stock | 1.12K | Direct | F3, F4 | |
transaction | ZBH | Restricted Stock Units | Options Exercise | $0 | -954 | -100% | $0.00* | 0 | Dec 3, 2022 | Common Stock | 954 | Direct | F3, F4 | |
transaction | ZBH | Restricted Stock Units | Options Exercise | $0 | -1.57K | -100% | $0.00* | 0 | Dec 3, 2022 | Common Stock | 1.57K | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Includes 203 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan since December 7, 2021. |
F2 | Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). |
F3 | Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. |
F4 | On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022. |